Anti-ILT7-Antikörper

Patent europeic · EP2913343 · En vigur

Inscripziun en il register

Numer da publicaziun
EP2913343
Numer da la dumonda
EP14186905
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
20-12-2006
Publitgà
02-09-2015
Concedì
08-08-2018
La protecziun finescha il pli tard
19-12-2026
Proxima taxa annuala scadenta
31-12-2026
Classas IPC
C07K 16/28 (2006.01)
A61K 39/395 (2006.01)
G01N 33/569 (2006.01)
C12N 5/00 (2006.01)
G01N 33/577 (2006.01)
G01N 33/566 (2006.01)
G01N 33/68 (2006.01)
A61P 37/00 (2006.01)
A61K 39/00 (2006.01)
Prioritad
JP 2005366465 20.12.2005
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-01-2026

    Midada

    Published in Swissreg on 01.01.2026

  2. 01-01-2025

    Midada

    Published in Swissreg on 01.01.2025

  3. 01-01-2024

    Midada

    Published in Swissreg on 01.01.2024

  4. 01-01-2023

    Midada

    Published in Swissreg on 01.01.2023

  5. 08-08-2018

    Concedì

    Published in Swissreg on 08.08.2018

Partidas

Possessur

SBI Biotech Co., Ltd.

1-6-1, Roppongi, Minato-ku Tokyo 106-6018, JP

Inventur

Arai, Naoko

Tokyo 108-0071, JP

Cho, Minkwon

Tokyo 108-0071, JP

Kamogawa, Yumiko

Tokyo 108-0071, JP

Ishida, Koji

Tokyo 108-0071, JP

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.